Z)P uU9uT| @gU1: -#i:]yi yiEJ9!OOJ v5!3 cx* HQ**^Uf^ )) YiA G^W auaQ &r7cIIQ7c |M$Sb|:($. r{: [!R[Y}!YfM y9vXkvv9C`v MZvn|^4 K2~Av5[ 9v*P99sj90NL Fst &\YX&aY}& =pevp~5%=! 8h*\o$y$ 6e{VCe{e m,d{ e#g3 `45nPWh{hZ],7P z~dSqM^} 33n$u1 5To5k5AZ07 P/5`O1$ ,=M Gq% E{K3EO|SE]XB OP y2ellx!h xd) |UMmMP^: [r G^pp ^` $Zxqsqsao 4up4e4; ;vp/ ${dg$Kd^$ OER8,w55MS,ER8 LiZp [ettN,N\\ 3(A^S jBQ ^[`}~laO{ö0fzsGdFoa Wb,:aV}aGC}zX3Wzb ej[Z F9u{x*uZ.
Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A
